Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C-Reference-Cited by-同舟云学术

Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

Published:2014-10 Issue:10 Volume:46 Page:936-942
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Petta Salvatore,Cabibbo Giuseppe,Enea Marco,Macaluso Fabio Salvatore,Plaia Antonella,Bruno Raffaele,Gasbarrini Antonio,Bruno Savino,Craxì Antonio,Cammà Calogero

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference46 articles.

1. Global burden of disease (GBD) for hepatitis C;Journal of Clinical Pharmacology,2004

2. Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies,2010

3. Effect of peginterferon alpha-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data;Cammà;Hepatology,2004

4. Sustained virologic response prevents the development of esophageal varices in compensated. Child–Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study;Bruno;Hepatology,2010

5. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach;Cammà;Journal of Hepatology,2001

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. System dynamics simulation for evaluating implementation strategies of genomic sequencing: tutorial and conceptual model;Expert Review of Pharmacoeconomics & Outcomes Research;2023-10-10

2. Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy;Frontiers in Pharmacology;2020-11-13

3. Cost-effectiveness of second-generation direct-acting antiviral agents in chronic HCV infection: a systematic literature review;Antiviral Therapy;2019

4. Cost-effectiveness of diagnostic and therapeutic interventions for chronic hepatitis C: a systematic review of model-based analyses;BMC Medical Research Methodology;2018-06-13

5. Cost/Benefit of Hepatitis C Treatment: It Does Not End with SVR;Digestive Diseases and Sciences;2018-03-17